Health Secretary Robert F. Kennedy Jr. Initiatives Draw Criticism and Restructuring at Federal Health Agencies

2026-07-06

The BareStory

Former Centers for Disease Control and Prevention (CDC) Chief Medical Officer Dr. Debra Houry has criticized Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., alleging that his actions caused "pure chaos" at the agency. Houry, who resigned last summer, claimed Kennedy sought to drastically alter CDC policies and personnel, including removing all 17 members of the Advisory Committee for Immunization Practices (ACIP) in June 2025. According to Houry, the standard process was bypassed to install allies on the panel, some of whom lacked medical, scientific, or government backgrounds. Kennedy defended the changes by arguing the original panel had become a "rubber stamp" for vaccines.

Under the reconstituted panel, votes were held to reduce recommended childhood vaccines, remove thimerosal from flu vaccines, and end the universal birth dose recommendation for the Hepatitis B vaccine. These changes prompted lawsuits from the American Academy of Pediatrics and other organizations. In March, a federal judge halted the new panel appointments, nullified their votes, and blocked the vaccine schedule changes. Additionally, Houry stated that the CDC was ordered to purge all mentions of gender from its websites within 11 days following an Inauguration Day executive order by President Trump targeting gender ideology. Houry also accused Kennedy of spreading misinformation about the measles vaccine and attempting to link autism to vaccines.

Separately, Kennedy is planning to restructure the U.S. Preventive Services Task Force, a government panel that decides which preventive health screenings insurers must fully cover. Kennedy criticized the task force as "lackadaisical and negligent," particularly for its refusal to mandate coverage for Alzheimer's disease testing. In May, Kennedy dismissed the panel's leadership and suspended most of its meetings, intending to appoint new members. An anonymous administration official defended the restructuring, stating it aims to address a task force that has been too slow to recommend preventive care.

The planned changes to the task force have drawn mixed reactions. Supporters, including certain patient advocacy groups and medical test manufacturers, argue the panel has been too slow to evaluate and recommend new screenings. Conversely, critics express concern that the panel could become unscientific, potentially requiring coverage for services that lack clinical evidence, benefit specific financial interests, or cause harm. According to Michael Sapienza, CEO of the Colorectal Cancer Alliance, the restructuring has stalled the task force's work, leaving it with no new recommendations for 16 months.

Left Perspective

Shielding Evidence-Based Medicine
Defending Inclusive Healthcare Delivery
Preventing Commercialized Medical Standards

Right Perspective

Challenging Regulatory Capture
Restoring Traditional Civic Mission
Accelerating Patient-Centric Innovation

Left Perspective

• Shielding Evidence-Based Medicine The integrity of public health relies on empirical science, rigorous peer review, and qualified expertise rather than political patronage. By attempting to bypass standard nomination processes to install allies lacking medical, scientific, or government backgrounds on the Advisory Committee for Immunization Practices, the leadership threatens to compromise the safety of childhood immunization schedules. When ideological agendas override clinical consensus—such as trying to restrict the Hepatitis B birth dose or remove thimerosal—it erodes public trust and necessitates judicial intervention to protect children's health.

• Defending Inclusive Healthcare Delivery A just healthcare system must recognize and address the specific medical needs of all populations without being hijacked by partisan culture wars. Forcing the CDC to purge all references to gender from its websites within an 11-day window represents an ideological censorship that undermines the agency's ability to communicate vital health guidelines to vulnerable communities. Erasing scientific terminology and diverse health considerations from public platforms prioritizes political posturing over the foundational duty of protecting patient well-being and civil liberties.

• Preventing Commercialized Medical Standards Insulating regulatory bodies from commercial interests is essential to prevent corporate extraction and ensure that insurance mandates are backed by rigorous clinical data. Dismantling the leadership of the U.S. Preventive Services Task Force risks turning an objective evaluation panel into a mechanism that forces coverage for unproven screenings, directly benefiting medical test manufacturers at the expense of patient safety and premium costs. Halting the task force’s operations for 16 months creates a dangerous bottleneck, stalling legitimate, life-saving diagnostic guidelines while opening the door to scientifically unsupported medical procedures.

Right Perspective

• Challenging Regulatory Capture National sovereignty and public trust require that federal agencies remain accountable to elected leadership rather than insular, self-governing boards. Dismantling and replacing the 17-member Advisory Committee for Immunization Practices is a necessary disruption of an agency culture that has become a "rubber stamp" for pharmaceutical interests rather than an objective evaluator of vaccine schedules. Restructuring these panels asserts the constitutional authority of the executive branch to oversee administrative bodies and ensure they serve the broader public interest rather than entrenched institutional status quos.

• Restoring Traditional Civic Mission Government agencies must focus on core public health duties and national unity rather than promoting divisive, non-consensus social theories. Aligning the CDC's public-facing materials with the administration's Inauguration Day executive order ensures the agency adheres to federal policy guidelines regarding gender ideology and focuses on universal health threats. Eliminating highly politicized language from official government platforms restores administrative neutrality and aligns agency communication with established biological and legal standards.

• Accelerating Patient-Centric Innovation Modernizing bureaucratic processes is essential to deliver timely, cutting-edge preventive care to the American public. The U.S. Preventive Services Task Force's sluggish evaluation system, exemplified by its refusal to mandate coverage for critical screenings like Alzheimer's disease testing, represents a "lackadaisical and negligent" approach to wellness that harms patients. Reconstituting this panel with reform-minded members breaks through regulatory inertia, forces faster adoption of life-saving diagnostic technologies, and prioritizes proactive wellness over administrative delay.

How it may affect me

As a U.S. reader:

• You may find that your child's immunization schedule remains unchanged for now, as a federal judge has blocked proposed reductions to recommended childhood vaccines and halted changes to the vaccine advisory panel.

• You will find that CDC websites no longer contain references to gender, following an executive order directing the agency to remove this terminology from its public platforms.

• You may experience a delay in accessing insurance-covered preventive health screenings, as the restructuring of the U.S. Preventive Services Task Force has stalled new recommendations for 16 months.

• Depending on the outcome of the task force restructuring, you could eventually see changes in your insurance coverage, potentially gaining faster access to new screenings like Alzheimer's disease testing, or conversely, facing higher premiums for unproven procedures.

Health Secretary Robert F. Kennedy Jr. Initiatives Draw Criticism and Restructuring at Federal Health Agencies

The BareStory

Left Perspective

Right Perspective

How it may affect me

Read the story at